Two Sigma Advisers’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-122,800
Closed -$2.21M 436
2025
Q4
$2.21M Sell
122,800
-67,400
-35% -$1.21M ﹤0.01% 1146
2025
Q3
$3.52M Sell
190,200
-1,374,000
-88% -$21.6M 0.01% 875
2025
Q2
$25M Sell
1,564,200
-175,600
-10% -$3.13M 0.05% 293
2025
Q1
$33.8M Sell
1,739,800
-71,300
-4% -$1.5M 0.08% 236
2024
Q4
$39.9M Buy
1,811,100
+470,000
+35% +$9.05M 0.09% 196
2024
Q3
$22.6M Buy
1,341,100
+120,000
+10% +$1.78M 0.05% 297
2024
Q2
$14.6M Buy
1,221,100
+52,200
+4% +$583K 0.03% 426
2024
Q1
$13M Sell
1,168,900
-10,000
-0.8% -$102K 0.03% 450
2023
Q4
$10.2M Buy
1,178,900
+827,700
+236% +$6.43M 0.02% 521
2023
Q3
$2.69M Buy
351,200
+271,300
+340% +$2.04M 0.01% 1041
2023
Q2
$575K Buy
+79,900
New +$466K ﹤0.01% 1765

Other funds holding CLBT